Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
Authors
Keywords
Sequence motif analysis, Cancer treatment, Cell migration, Chemokines, Lung and intrathoracic tumors, Secondary lung tumors, Melanoma cells, Cell binding
Journal
PLoS One
Volume 8, Issue 9, Pages e74548
Publisher
Public Library of Science (PLoS)
Online
2013-09-14
DOI
10.1371/journal.pone.0074548
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of stromal CXCR4 impairs development of lung metastases
- (2012) Crescenzo D’Alterio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CXCL12 (SDF1 )-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
- (2011) D. G. Duda et al. CLINICAL CANCER RESEARCH
- Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4
- (2011) M P Rettig et al. LEUKEMIA
- Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local Irradiation
- (2010) S. V. Kozin et al. CANCER RESEARCH
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth
- (2010) Katia Beider et al. EXPERIMENTAL HEMATOLOGY
- The Peptidomimetic CXCR4 Antagonist TC14012 Recruits β-Arrestin to CXCR7
- (2010) Stéphanie Gravel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
- (2010) Mitomu Kioi et al. JOURNAL OF CLINICAL INVESTIGATION
- Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
- (2010) Sigal Tavor et al. SEMINARS IN CANCER BIOLOGY
- The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
- (2009) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
- (2009) A. Levoye et al. BLOOD
- Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1 , CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer
- (2009) L. Xu et al. CANCER RESEARCH
- Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands
- (2009) B. A. Zabel et al. JOURNAL OF IMMUNOLOGY
- Advances in mobilization for the optimization of autologous stem cell transplantation
- (2009) Julie M. Vose et al. LEUKEMIA & LYMPHOMA
- An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells
- (2009) J. Kwong et al. MOLECULAR CANCER THERAPEUTICS
- Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth
- (2009) Stacy Porvasnik et al. PROSTATE
- Control of Chemokine-Guided Cell Migration by Ligand Sequestration
- (2008) Bijan Boldajipour et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search